000 | 01929 a2200517 4500 | ||
---|---|---|---|
005 | 20250514192655.0 | ||
264 | 0 | _c20040728 | |
008 | 200407s 0 0 eng d | ||
022 | _a0024-3205 | ||
024 | 7 |
_a10.1016/j.lfs.2004.03.008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHsu, Ya-Ling | |
245 | 0 | 0 |
_aThe proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. _h[electronic resource] |
260 |
_bLife sciences _cJul 2004 |
||
300 |
_a1231-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aCell Division _xdrug effects |
650 | 0 | 4 |
_aCell Line, Tumor _xdrug effects |
650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
650 | 0 | 4 |
_aCyclins _xmetabolism |
650 | 0 | 4 |
_aDNA, Neoplasm _xanalysis |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFas Ligand Protein |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMedicine, Chinese Traditional |
650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
650 | 0 | 4 |
_aOleanolic Acid _xanalogs & derivatives |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xmetabolism |
650 | 0 | 4 | _aProto-Oncogene Proteins c-bcl-2 |
650 | 0 | 4 | _aReagent Kits, Diagnostic |
650 | 0 | 4 |
_aSaponins _xpharmacology |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
650 | 0 | 4 | _abcl-2-Associated X Protein |
650 | 0 | 4 |
_afas Receptor _xmetabolism |
700 | 1 | _aKuo, Po-Lin | |
700 | 1 | _aLin, Chun-Ching | |
773 | 0 |
_tLife sciences _gvol. 75 _gno. 10 _gp. 1231-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.lfs.2004.03.008 _zAvailable from publisher's website |
999 |
_c14924855 _d14924855 |